WaferGen Bio-systems, Inc. (WBSI) is engaged in the development, manufacture and marketing of laboratory analytical instruments for cell biology, and later started the development of analytical instrumentation for gene expression and genotyping research for the life sciences and pharmaceutical drug discovery industries. WBSI is primarily focused on developing a gene expression and genotyping product, the WaferGen SmartChip System. The Company has first generation SmartChip 5K System, which is a polymerase chain reaction (real-time PCR)2 tool to enable scientists to study thousands of genes simultaneously based on gene specific pathways, potentially to discovery of clinically relevant disease signatures. It also provides in-house gene-expression profiling for sales demonstrations and collaborations using the SmartChip System. In January 2014, the Company announced that it has completed the acquisition of the NGS library preparation business from IntegenX Inc.